CTOs on the Move

Sugarlogix, whose mission is to create functional sugars with health benefits, is a bioengineering company that makes human milk oligosaccharides (HMOs) for infant nutrition. HMOs are the fiber-equivalents in human breast milk that play crucial prebiotic functions in babies` guts. Sugarlogix` novel HMO-producing technologies offer safe and affordable HMOs for babies without access to breast milk. Founded in 2016 and led by Co-Founder and CEO Chaeyoung Shin, Sugarlogix is headquartered in Oakland and is financially backed by 8VC, Berkeley Catalyst Fund, and SOSV and private investors.